Injectable disease modifying agents in multiple sclerosis: pattern of medication use and clinical effectiveness
The objective of this study was to assess long-term use, adherence and efficacy of injectable disease modifying agents (DMAs). Multiple Sclerosis (MS) patients diagnosed during 2002-2010 with early treatment start and at least one year in first choice medication were included in a large university d...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2016-09-01
|
| Seri Bilgileri: | Neurology International |
| Konular: | |
| Online Erişim: | http://www.pagepress.org/journals/index.php/ni/article/view/6513 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|